Assessing Biomarkers in the Eye for Better Clinical Outcomes

Zilia is developing a groundbreaking technology bound to redefine the way we prevent, diagnose, and treat various ocular, neurological, and systemic conditions.

Zilia’s technology provides health care professionals with new key clinical insight.

Why the Eye?

The eye is a unique window into a person’s health. Due to its relationship to the brain and the vascular system, the eye is an ideal setting to non-invasively monitor biomarkers related to ocular, neurological, and systemic diseases.

Ocular Biomarkers
Zilia Biomarkers

Assessment of Biomarkers in the Eye

We are developing a disruptive technology using imaging, spectrometry, and AI to identify and quantify biomarkers in the eye.

Measuring Oxygen Saturation in the Eye

Zilia Ocular is the first retinal camera to provide continuous measurements of oxygenation in the human eye.

Retinal Oximetry
fightingblindness

What if we Could Prevent Vision Loss?

As oxygenation of the eye is a crucial biomarker in the leading causes of vision loss, such as glaucoma, diabetic retinopathy, and age-related macular degeneration, Zilia’s first product is bound to revolutionize the prevention, diagnosis, and treatment.

Our Partners

HemaQuebec
University_of_Houston_logo
Universite_de_Montreal_logo
University_of_California,_Berkeley_logo
University_of_California,_San_Diego_logo
logo.CERVO